Company filings, made visual.

Find a company. Follow its revenue through costs and profit.

Market

Find a company or ticker

Coverage includes separate ticker and security records; counts are not unique companies.

Tandem Diabetes Care, Inc.

TNDM

Filing: SEC 10-Q
Period: Three months ended March 31, 2026
Basis: Editorial filing; Read original SEC 10-Q ↗

Sankey diagram of Tandem Diabetes Care, Inc.. A complete text table follows the diagram.

Tandem insulin-delivery platform

Insulin pumps and supplies serve a connected diabetes-management ecosystem with recurring product demand.

Swipe to explore

Source & review

Read original SEC 10-Q ↗

SEC accession: 0001438133-26-000049
Filed: Date not recorded
Reviewed: Date not recorded
Status: Individual filing review complete

How to read these figures

The operating total is directly reported in the downloaded filing. Editorial language identifies the company-specific business engine; no unreported allocation is introduced.

Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.

The flow starts from the filing-reported operating total; the destination names the business engine described in the filing.
No segment split is shown where the filing did not provide a defensible consolidated allocation for this visual.

View accessible tables

Financial categories · Three months ended March 31, 2026 · Millions of USD
Category	Stage	Value	Notes
Reported operating total	1	$247M	Directly reported in the downloaded 10-Q
Insulin-delivery platform	2	$247M	Insulin pumps and supplies serve a connected diabetes-management ecosystem with recurring product demand.

Financial flows · Millions of USD
From	To	Value
Reported operating total	Insulin-delivery platform	$247M